The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response
- Leandro Castellanoa,1,
- Georgios Giamasa,
- Jimmy Jacoba,
- R. Charles Coombesa,
- Walter Lucchesib,
- Paul Thiruchelvama,
- Geraint Bartonc,
- Long R. Jiaod,
- Robin Waite,
- Jonathan Waxmana,
- Gregory J. Hannonf and
- Justin Stebbinga,1
- aDepartment of Oncology, Cyclotron Building, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, United Kingdom;
- bDepartment of Cellular and Molecular Science, Burlington Dane's Building, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, United Kingdom;
- cCentre for Bioinformatics, Division of Molecular Biosciences, Faculty of Natural Sciences, Biochemistry Building, South Kensington Campus, Imperial College, London SW7 2AZ, United Kingdom;
- dDivision of Surgery, Oncology, Reproductive Biology and Anaesthesia, Hammersmith Hospital, Imperial College, Du Cane Road, London W12 0NN, United Kingdom;
- eThe Kennedy Institute, Faculty of Medicine, Imperial College, Charing Cross Hospital Campus, London W6 8LH, United Kingdom; and
- fWatson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory (CSHL), 1 Bungtown Road, Cold Spring Harbor, NY 11724
-
Edited by Bert W. O'Malley, Baylor College of Medicine, Houston, TX, and approved July 22, 2009 (received for review June 24, 2009)
Abstract
Following estrogenic activation, the estrogen receptor-α (ERα) directly regulates the transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERα have the potential to fine tune these regulatory systems and also provide an alternate mechanism that could impact on estrogen-dependent developmental and pathological systems. Through a microarray approach, we identify the subset of microRNAs (miRNAs) modulated by ERα, which include upregulation of miRNAs derived from the processing of the paralogous primary transcripts (pri-) mir-17–92 and mir-106a-363. Characterization of the mir-17–92 locus confirms that the ERα target protein c-MYC binds its promoter in an estrogen-dependent manner. We observe that levels of pri-mir-17–92 increase earlier than the mature miRNAs derived from it, implicating precursor cleavage modulation after transcription. Pri-mir-17–92 is immediately cleaved by DROSHA to pre-miR-18a, indicating that its regulation occurs during the formation of the mature molecule from the precursor. The clinical implications of this novel regulatory system were confirmed by demonstrating that pre-miR-18a was significantly upregulated in ERα-positive compared to ERα-negative breast cancers. Mechanistically, miRNAs derived from these paralogous pri-miRNAs (miR-18a, miR-19b, and miR-20b) target and downregulate ERα, while a subset of pri-miRNA-derived miRNAs inhibit protein translation of the ERα transcriptional p160 coactivator, AIB1. Therefore, different subsets of miRNAs identified act as part of a negative autoregulatory feedback loop. We propose that ERα, c-MYC, and miRNA transcriptional programs invoke a sophisticated network of interactions able to provide the wide range of coordinated cellular responses to estrogen.
Footnotes
- 1To whom correspondence may be addressed: E-mail: l.castellano{at}imperial.ac.uk or j.stebbing{at}imperial.ac.uk
-
Author contributions: L.C., J.W., G.J.H., and J.S. designed research; L.C., J.J., W.L., P.T., R.W., and J.S. performed research; L.C., G.G., J.J., R.C.C., W.L., P.T., L.R.J., and J.S. contributed new reagents/analytic tools; L.C., G.G., J.J., G.B., R.W., and J.S. analyzed data; and L.C. and J.S. wrote the paper.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0906947106/DCSupplemental.










